We’re proud to announce our participation in the ESGCT Congress 2025, held from October 7 to 10 in Seville, Spain.
This key event brings together experts in gene and cell therapy from around the world.
Our Business Developers, Ha-Yeon Kim-Penard, PhD, and Philippe Michon, will be attending to connect with innovators and discuss how our humanized mouse models can support the next generation of CGT programs.
Whether you’re designing your first in vivo study or optimizing a complex therapeutic platform, our team is here to help you find the most relevant, ethical, and efficient preclinical strategy.
Let’s connect in Seville!